Zheng Yanyi, Xu Leiming, Zhang Silu, Liu Yanwen, Ni Jiayi, Xiao Guoxun
Shenzhen Precision Health Food Technology Co., Ltd., Shenzhen, China.
Department of Gastroenterology, Shanghai Jiaotong University Affiliated Xinhua Hospital, Shanghai, China.
Front Nutr. 2023 Jul 10;10:1196625. doi: 10.3389/fnut.2023.1196625. eCollection 2023.
Our aim was to determine the efficacy of four-week probiotic supplementation on gastrointestinal health. The secondary objectives were to assess probiotic effects on immune reaction, as well as weight control and metabolic health.
We conducted two randomized sub-trials, respectively, among subjects who were diagnosed with functional constipation (FC) or functional diarrhea (FDr) according to the Rome IV criteria. In each sub-trial, 70 eligible Chinese adults were randomized to receive a multi-strain probiotic combination or a placebo. Gastrointestinal symptoms, defecation habits, stool characteristics, blood and fecal biochemistry markers, anthropometrics measures, stress-associated responses, and intestinal flora changes were assessed at baseline and after probiotics intervention.
Four weeks of probiotic supplementation reduced overall gastrointestinal symptoms scores in FC participants ( < 0.0001). Their mean weekly stool frequency increased from 3.3 times to 6.2 times; immune response and inflammation markers improved with increases in serum IgA, IFN-γ and fecal sIgA, and decrease in hsCRP; most components of lipid profile were significantly ameliorated, with increases in HDL-C and reductions in TC and TG; body weight, body mass index and basal metabolic rate decreased following probiotics consumption. For FDr participants, probiotics consumption markedly reduced overall gastrointestinal symptom scores ( < 0.0001); decreased stool frequency by 3 times per week; increased IgA, IFN-γ, sIgA concentrations, while lowered hsCRP and IL-4 levels. Both FC and FDr participants had improvement in the scores of defecation habits, anxiety or depression, and perceived stress. Probiotics supplementation promoted the production of all three major short-chain fatty acids. No changes were observed in LDL-C, IgG, IgM, IL-8, IL-10 and motilin.
Supplementation with the probiotic formula over a four-week period could help relieving gastrointestinal symptoms, improving satisfaction with defecation habits, emotional state and immune response, and ameliorating dysbacteriosis in participants with FC or FDr. It also had beneficial effects on lipid metabolism and weight control for FC participants.
我们的目的是确定四周补充益生菌对胃肠道健康的功效。次要目的是评估益生菌对免疫反应以及体重控制和代谢健康的影响。
我们分别在根据罗马IV标准被诊断为功能性便秘(FC)或功能性腹泻(FDr)的受试者中进行了两项随机子试验。在每个子试验中,70名符合条件的中国成年人被随机分配接受多菌株益生菌组合或安慰剂。在基线和益生菌干预后评估胃肠道症状、排便习惯、粪便特征、血液和粪便生化指标、人体测量指标、应激相关反应以及肠道菌群变化。
四周补充益生菌降低了FC参与者的总体胃肠道症状评分(<0.0001)。他们的平均每周排便次数从3.3次增加到6.2次;免疫反应和炎症指标随着血清IgA、IFN-γ和粪便sIgA的增加以及hsCRP的降低而改善;血脂谱的大多数成分得到显著改善,HDL-C升高,TC和TG降低;食用益生菌后体重、体重指数和基础代谢率下降。对于FDr参与者,食用益生菌显著降低了总体胃肠道症状评分(<0.0001);每周排便次数减少3次;IgA、IFN-γ、sIgA浓度升高,而hsCRP和IL-4水平降低。FC和FDr参与者的排便习惯、焦虑或抑郁以及感知压力评分均有所改善。补充益生菌促进了所有三种主要短链脂肪酸的产生。LDL-C、IgG、IgM、IL-8、IL-10和胃动素未观察到变化。
在四周内补充益生菌配方有助于缓解胃肠道症状,提高对排便习惯、情绪状态和免疫反应的满意度,并改善FC或FDr参与者的菌群失调。它对FC参与者的脂质代谢和体重控制也有有益影响。